Cargando…
Telomere shortening accelerates tumor initiation in the L2-IL1B mouse model of Barrett esophagus and emerges as a possible biomarker
Barrett’s esophagus (BE) is a precursor of the esophageal adenocarcinoma (EAC). BE- development and its progression to cancer is associated with gastroesophageal reflux disease. However, there is currently no molecular risk prediction model that accurately identifies patients at high risk for EAC. H...
Autores principales: | Sahm, Vincenz, Maurer, Carlo, Baumeister, Theresa, Anand, Akanksha, Strangmann, Julia, Schmid, Roland M., Wang, Timothy C., Quante, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842791/ https://www.ncbi.nlm.nih.gov/pubmed/35178191 http://dx.doi.org/10.18632/oncotarget.28198 |
Ejemplares similares
-
Targeted Hsp70 fluorescence molecular endoscopy detects dysplasia in Barrett’s esophagus
por: Fang, Hsin-Yu, et al.
Publicado: (2021) -
High-Fructose Diet Alters Intestinal Microbial Profile and Correlates with Early Tumorigenesis in a Mouse Model of Barrett’s Esophagus
por: Proaño-Vasco, Andrea, et al.
Publicado: (2021) -
CXCR4 peptide-based fluorescence endoscopy in a mouse model of Barrett’s esophagus
por: Marcazzan, Sabrina, et al.
Publicado: (2022) -
Notch signaling drives development of Barrett’s metaplasia from Dclk1-positive epithelial tuft cells in the murine gastric mucosa
por: Kunze, Bettina, et al.
Publicado: (2021) -
DNA methylation markers for disease progression and survival in Barrett’s Esophagus
por: Taenzer, Marc, et al.
Publicado: (2013)